Genomics Investment Syndicate III ApS — Credit Rating and Financial Key Figures

Genomics Investment Syndicate III ApS (CVR number: 25589327) is a company from SKIVE. The company recorded a gross profit of -8.7 kDKK in 2023. The operating profit was -8.7 kDKK, while net earnings were -32.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.8 %, which can be considered poor and Return on Equity (ROE) was -11.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 24.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Genomics Investment Syndicate III ApS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.